Venebio

Venebio Group, LLC is a hybrid life sciences company combining a global scientific consultancy with a proprietary technology development arm. Its consulting division delivers expertise in epidemiology, biostatistics, real-world evidence, and regulatory strategy to pharmaceutical, device, and legal clients. The technologies division has developed two commercialized clinical decision support tools targeting the opioid epidemic and statin therapy optimization, leveraging algorithms to provide patient-specific risk assessments and dosing guidance. This dual-model approach generates service revenue while pursuing scalable product opportunities in digital health.

Algorithm-based platform for developing personalized clinical decision support (CDS) tools. It uses patient-specific data and evidence-based algorithms to generate risk assessments and therapeutic recommendations for medication management.

In consulting, Venebio competes with large global CROs (IQVIA, Parexel) and specialized boutiques in epidemiology and HEOR. For its CDS tools, competitors range from EHR-embedded clinical guidelines (Epic, Cerner) and large digital health platforms to niche point-solutions focused on opioid risk (e.g., Bamboo Health, Appriss Health's NarxCare) and medication management. Venebio's differentiation is its deep scientific research foundation and hybrid service-product model.